6 completed, 1 unknown. 4 Phase 3, 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow albutrepenonacog alfa: new trials by email Literature Review of albutrepenonacog alfa trials Research Report on albutrepenonacog alfa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy Recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) - Hemophilia B | Phase 3 | Completed | CSL Behring | 23 | 2024-07-28 | 2026-07-23 |
| The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients Albutrepenonacog Alfa 1 UNT [IDELVION] - Hemophilia | Phase 4 | Unknown | National Taiwan University Hospital | 5 | 2020-04-21 | 2020-10-30 |
| ATHN 2: Factor Switching Study Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013, Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 - Hemophilia | Completed | American Thrombosis and Hemostasis Network | 310 | 2015-09-01 | 2021-12-09 | |
| A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B rIX-FP - Hemophilia B | Phase 3 | Completed | CSL Behring | 97 | 2014-02-06 | 2022-07-14 |
| A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B rIX-FP - Hemophilia B | Phase 3 | Completed | CSL Behring | 27 | 2013-01-01 | 2016-05-09 |
| A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B rIX-FP - Hemophilia B | Phase 2 / Phase 3 | Completed | CSL Behring | 63 | 2012-02-01 | 2016-05-09 |
| A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B Recombinant Coagulation Factor IX Albumin Fusion Protein - Hemophilia B | Phase 1 / Phase 2 | Completed | CSL Behring | 17 | 2011-07-01 | 2016-05-09 |
Hemophilia B (5) · Hemophilia A (2) · Hemorrhage (1) · Thrombosis (1)
CSL Behring (5) · American Thrombosis and Hemostasis Network (1) · National Taiwan University Hospital (1)
Israel (4) · Austria (3) · Bulgaria (3) · France (3) · Germany (3) · Italy (3) · Spain (3) · United States (3) · Australia (2) · Canada (2) · Czechia (2) · Japan (2) · Russia (2) · China (1) · Malaysia (1)
Ellis J Neufeld, MD, PhD (1) · Iris Jacobs, MD (1) · Janna Journeycake, MD (1)